Hologen AI Commits Up to $430 Million to Advance MeiraGTx’s Parkinson’s Gene Therapy to Phase 3 and Beyond

March 18, 2025

FDA Under Trump Reduces Use of Advisory Committees in Drug Approvals

September 15, 2025

Illumina Decides to Spin Off Grail

June 6, 2024

Must Read

What Happens When AI Becomes a Scientific Co-Pilot?

May 14, 2026

Digital Twins in Healthcare: Hype, Reality, and Future Applications

May 14, 2026

How Pharmaceutical Companies Are Using AI for Faster Regulatory Submissions

May 14, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

What Happens When AI Becomes a Scientific Co-Pilot?

Digital Twins in Healthcare: Hype, Reality, and Future Applications

How Pharmaceutical Companies Are Using AI for Faster Regulatory Submissions

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Editorial Team

GSK Returns WVE-006 Rights to Wave Following Phase Ib/IIa AATD Results

Editor Picks

Hologen AI Commits Up to $430 Million to Advance MeiraGTx’s Parkinson’s Gene Therapy to Phase 3 and Beyond

FDA Under Trump Reduces Use of Advisory Committees in Drug Approvals

Illumina Decides to Spin Off Grail

Must Read

What Happens When AI Becomes a Scientific Co-Pilot?

Digital Twins in Healthcare: Hype, Reality, and Future Applications

How Pharmaceutical Companies Are Using AI for Faster Regulatory Submissions

Hot Topics

About Us

Follow Us